449 third-party lab reports published Volume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded 99.59% median purity across 254 lots 242 / 242 lots pass sterility

‹ Certificates Tesamorelin Lot 1669

Lab report (Certificate of Analysis, COA)

Tesamorelin · 10 mg

Batch 1669 · tested February 4, 2026 (235 days ago) · released May 25, 2026

All tests passed

Batch
#1669 9 tests
Mass
10 mg
Purity
99.46%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

1 unit tested for purity: 99.46% as printed

Conformity: Not assessable — every reported unit passed on all 6 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-02-04

Vanguard · issuing labEagle Analytical · sterility

Verified by Vanguard Laboratory

This certificate is also hosted by Vanguard Laboratory — the issuing lab — on its own verification site.

View on VerifiedByVanguard.com
Laboratory ID V260119-8 007

Reports for this lot

  1. Vanguard Laboratory this report · tested February 4, 2026 · 6 results · QA approvalVanguard · issuing labEagle Analytical · sterilityAll tests passed

Test by test

6 results on the report · 3 rows computed from the per-unit values · 2 labs · each test used up to 1 vial from this lot (rows are not added together) · every row names the chapter or house rule it follows

✓PurityWithin limits
99.46% · 1 unit · USP <621> (procedural chapter)
–Purity consistency between unitsSingle measurement
1 unit measured (99.46%) · a between-unit spread needs two or more measured units
✓Net peptide content (assay)Within limits
11.50 mg · 1 unit · USP <621> (procedural chapter)
–Content consistency between unitsSingle measurement
1 unit printed (11.50 mg) · a between-unit spread needs two or more measured units
✓Heavy metalsWithin limits
all non-detect · 1 unit · dose-scaled limits derived from USP <232> (limits chapter)
–Residual solventsNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–TFA residualNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
✓EndotoxinsWithin limits
<5.00 · 1 unit · USP <85> (procedural chapter) · limit <5.00 EU/mg (the lab's)
–Container closureNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–SolubilityNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
✓SterilityPass
1 of 1 pass · 1 unit · USP <71> (procedural chapter)
✓SterilityPass
1 of 1 pass · 1 unit · USP <71> (reference) · a rapid viability test used as an alternative to the USP <71> growth test; USP <1223> is the validation framework (informational chapter) · at Eagle Analytical
–ConformityNot assessable
every reported unit passed on all 6 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-02-04 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Eagle Analytical Services Inc. · Released May 25, 2026

Permanent URL: https://peptidology.co/coa/tesamorelin-lot-1669/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 3 times.